Abstract |
Evidence is accumulating indicating a role for uric acid in the genesis and progression of kidney disease, and a few studies are beginning to show a possible beneficial effect of urate-lowering therapy. Whether this holds true for renal allograft recipients is not clear. In this short review evidence from epidemiological as well as intervention studies is summarized and discussed, with some practical considerations presented at the end.
|
Authors | Gianni Bellomo |
Journal | World journal of nephrology
(World J Nephrol)
Vol. 4
Issue 3
Pg. 324-9
(Jul 06 2015)
ISSN: 2220-6124 [Print] United States |
PMID | 26167455
(Publication Type: Journal Article)
|